Securian Asset Management Inc Buys 93 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Securian Asset Management Inc increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.2% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 42,263 shares of the medical research company’s stock after acquiring an additional 93 shares during the period. Securian Asset Management Inc’s holdings in Thermo Fisher Scientific were worth $12,412,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of TMO. Ipswich Investment Management Co. Inc. raised its position in shares of Thermo Fisher Scientific by 0.5% during the 2nd quarter. Ipswich Investment Management Co. Inc. now owns 7,773 shares of the medical research company’s stock valued at $2,283,000 after acquiring an additional 35 shares during the last quarter. Van Hulzen Asset Management LLC raised its position in shares of Thermo Fisher Scientific by 3.1% during the 1st quarter. Van Hulzen Asset Management LLC now owns 1,197 shares of the medical research company’s stock valued at $328,000 after acquiring an additional 36 shares during the last quarter. Intrust Bank NA raised its position in shares of Thermo Fisher Scientific by 1.0% during the 1st quarter. Intrust Bank NA now owns 4,213 shares of the medical research company’s stock valued at $1,153,000 after acquiring an additional 42 shares during the last quarter. V Wealth Advisors LLC raised its position in shares of Thermo Fisher Scientific by 0.9% during the 2nd quarter. V Wealth Advisors LLC now owns 5,035 shares of the medical research company’s stock valued at $1,479,000 after acquiring an additional 46 shares during the last quarter. Finally, MBM Wealth Consultants LLC raised its position in shares of Thermo Fisher Scientific by 3.4% during the 2nd quarter. MBM Wealth Consultants LLC now owns 1,401 shares of the medical research company’s stock valued at $415,000 after acquiring an additional 46 shares during the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.

In other news, Director C Martin Harris sold 275 shares of the business’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $270.73, for a total value of $74,450.75. Following the completion of the transaction, the director now owns 6,433 shares of the company’s stock, valued at approximately $1,741,606.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the completion of the transaction, the chief financial officer now directly owns 40,029 shares of the company’s stock, valued at approximately $10,739,380.41. The disclosure for this sale can be found here. Insiders sold a total of 52,775 shares of company stock valued at $14,986,676 in the last three months. 0.45% of the stock is owned by company insiders.

Several analysts have commented on TMO shares. Argus upped their target price on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. UBS Group upped their target price on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the company a “buy” rating in a research report on Thursday, May 23rd. Needham & Company LLC upped their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. BTIG Research upped their target price on shares of Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a research report on Thursday, May 23rd. Finally, Wolfe Research started coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 30th. They set an “outperform” rating for the company. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $303.17.

Shares of TMO stock traded down $1.53 on Tuesday, hitting $277.99. The stock had a trading volume of 331,810 shares, compared to its average volume of 1,574,825. Thermo Fisher Scientific Inc. has a twelve month low of $208.34 and a twelve month high of $305.45. The firm has a market cap of $110.59 billion, a P/E ratio of 25.00, a PEG ratio of 1.81 and a beta of 1.11. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.58. The company has a fifty day moving average price of $286.07 and a two-hundred day moving average price of $272.21.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The company had revenue of $6.32 billion during the quarter, compared to analyst estimates of $6.31 billion. During the same quarter in the previous year, the business earned $2.75 EPS. The firm’s revenue was up 3.9% on a year-over-year basis. On average, analysts expect that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, September 17th will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.83%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: The Discount Rate – What You Need to Know

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.